[Addiction to Ephedrine in Psychiatric Disorders].
[Addiction to ephedrine in psychiatric disorders].
Adicciones. 2013; 25(1): 89-90
Martínez-Quintana E, Rodríguez-González F
EMCDDA Best Practice Promotion in Europe: an Internet based dissemination tool.
Adicciones. 2013; 25(1): 3-6
Ferri M, Bo A
Best… Continue reading
Melatonin and Its Agonists in Pain Modulation and Its Clinical Application.
Melatonin and its agonists in pain modulation and its clinical application.
Arch Ital Biol. 2012 Dec; 150(4): 274-92
Srinivasan V, Zakaria R, Jeet Singh H, Acuna-Castroviejo D
Melatonin, the hormone of darkness has many physiological functions in the body… Continue reading
True and False Concerns About Neuroenhancement: A Response to ‘Neuroenhancers, Addiction and Research Ethics’, by D M Shaw.
True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw.
J Med Ethics. 2013 Mar 6;
Heinz A, Kipke R, Müller S, Wiesing U
In his critical comment on our paper… Continue reading
[Antidepressant Activities of Flavonoids From Glycyrrhiza Uralensis and Its Neurogenesis Protective Effect in Rats].
[Antidepressant activities of flavonoids from Glycyrrhiza uralensis and its neurogenesis protective effect in rats].
Yao Xue Xue Bao. 2012 Dec; 47(12): 1612-7
Fan ZZ, Zhao WH, Guo J, Cheng RF, Zhao JY, Yang WD, Wang YH, Li W, Peng… Continue reading
Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing.
Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing.
PLoS One. 2013; 8(2): e57140
Kandeel M, Kitade Y
RNA interference (RNAi) is a highly specialized process of protein-siRNA interaction… Continue reading